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Down syndrome has a population prevalence of 1/650 to 1/1,000 live births
[1,2].  Despite a 
high uptake of prenatal testing and elective termination of affected pregnancies the birth prevalence 
of Down syndrome has remained stable or even increased during the last two decades in a number 
of countries
[1,3].  The principal reason  for this phenomenon is  the positive association  between 
Down syndrome conceptions and advanced maternal age
[4], coupled with the continuing trend of 
women delaying child-bearing to later ages
[3]. 
In developed countries over 90% of children born with Down syndrome now live to 10 
years of age and median life expectancy at birth has increased to approximately 60 years, up from 
just 12 years of age in the 1950s
[5,6].  Survival estimates have improved significantly through by 
early correction of congenital heart defects
[7-9] as well as more focused treatment of infections, 
betterenhanced nutrition, and improved general health care. 
 
Comorbidities in Down syndrome 
Down  syndrome  is  associated  with  a  wide  range  of  comorbidities  across  different  life 
phases
[1].    Early  childhood  disorders  have  been  well  described,  for  example,  congenital  heart 
defects
[10],  reduced  immunological  function
[11],  and  a  predisposition  to  acute  lymphocytic 
leukaemia
[12] which can continue to pose serious concerns throughout the lifespan.  However, other 
major comorbidities develop during and after childhood with some disease states only diagnosed at 
advanced ages
[13].  In addition, Down syndrome is associated with premature ageing, becoming 
apparent  around  40  years  of  age,  i.e.  some  20  years  earlier  than  in  members  of  the  general 
population.  Therefore with a median life expectancy of approximately 60 years individuals may be 
at risk of a range of age-related diseases over an extended period of their lives
[1,14]. 
To  examine  these  issues  data  were  collated  from  studies  which  observed  five  common 
comorbidities affecting adults with Down syndrome, visual and hearing defects, epilepsy, thyroid 
disorders, and Alzheimer disease, at specific age intervals
[15-22].  Only studies with data reported per 
decade of life were included.  Figure 1 depicts how the prevalence of most of these conditions 
increases sharply after 40 years of age, and how at this age people with Down syndrome are subject 
to a high risk of significant multiple morbidities and a consequent need for ongoing specialist care.  
Secondary conditions such as osteoporosis, obesity, diabetes and poor dentition are also expected to 
develop  with  advancing  age
[13],  with  their  ill-effects  exacerbated  by  long-term  medication, 
polypharmacy, immobility, and general inactivity. 
 
Challenges in the delivery of health care to people with Down syndrome 
Three main questions relatinged to the delivery of health care can be identified: 
Formatted: Superscript1.  Are comorbidities being detected in a timely manneradequately? 
Relatively  few  published  studies  have  included  sufficient  numbers  of  adult  cases  to 
demonstrate the specific age-related disease patterns that emerge in Down syndrome.  Besides small 
sample sizes, inappropriate descriptors such as ‘above 18 years’ or ‘under 50 years vs over 50 
years’ are often applied.  Analyses of this nature are insufficiently robust or precise to identify the 
important decadal changes in health that commonly arise in people with Down syndrome.  The 
paucity of available data implies that health professionals may be inadequately informed about the 
timing and nature of Down syndrome comorbidities, thus precluding the adoption of appropriate 
screening schedules. 
Sets of health guidelines for adults with Down syndrome have nevertheless been published to 
encourage  primary  health  care  providers  to  perform  regular  health  checks
[23].    However  tThe 
guidelines are, however, generally broad in nature, they occasionally vary in the advice proffered, 
and they usually are compiled without consideration of the timing of symptom onset or possible 
interactions  between  comorbid  conditions.    It  is  generally  recommended  that  annual  medical 
appointments are arranged
 to review medications, screen for expected comorbidities, and consider 
the emergence of prospective illnesses
[24].  But European studies have shown that many adults with 
Down syndrome fail to receive regular medical appointments and therefore health checks are not 
applied
[25,26].  Of greater concern, an Australian survey of children and adolescents with Down 
syndrome indicated a decreasing mean number of regular general practitioner visits even by late 
childhood
[27]. 
In the absence of formally implemented strategies for adult health care it is likely that: i) 
many people with Down syndrome are not regularly screened; ii) interventions are only introduced 
when problems have become clinically apparent, with the onset of treatments delayed; iii) different 
conditions  are  treated  in  isolation;  and  iv)  untreated  health  problems  may  result  in  additional 
disadvantageous complications.  Communication difficulties frequently prevent individuals with the 
disorder  from  conveying  symptoms  adequately  and  providing  descriptive  information,  with 
awareness  of  illness  initially  noticed  via  behavioural  changes  that  require  interpretation  by  a 
vigilant  carer  or  clinician.    It  therefore  is  important  for  carers  and  physicians  to  be  aware  of 
appropriate  regimens  to  maintain  health  with  regular  screening  for  emerging  health  issues
[28],
 
particularly  as  people  with  intellectual  disability  are  seldom  targeted  in  community  health 
promotion programmes
[29]. 
 
2.  Is the clinical progression of Down syndrome adequately understood? 
The combination of age-related comorbidities and positive improvements in survival statistics 
over the last half-century necessitates a more detailed investigation into the natural progression and longitudinal patterns of comorbidities of the life course in of Down syndrome, especially since .  As 
the phenomenon of old age in people with the disorder Down syndrome is relatively recent, detailed 
investigation into the natural progression of the disorder and longitudinal patterns of comorbidities 
is needed..  Although certain comorbidities have been identified that and are common to mostany 
people with Down syndrome, many cases not all people exhibit dissimilar health the same health 
historiesy  suggesting  particular  health  trajectories  within  Down  syndrome  itself.    Isolating  and 
ascribing these patterns of disease to particular subgroups will increase our understanding of their 
predetermined health outcomes and the requirement for more personalised care schedules. 
An individual’s The birth cohort should be considered as an important variable in longitudinal 
analyses,  as  since  people  individuals  born  in  more  recent  decades  predictably  would  have 
experienced different care protocols which in turn would impact on their overall health status.  A 
prime example of this transition in care is the highly significant positive impact of early surgical 
intervention on the survival of the estimated 40-50% of infants with Down syndrome diagnosed 
with a congenital heart defect
[[30,8]8,30]. 
 
3.  Who is responsible for the provision of care? 
According to normalisation principles people with Down syndrome are encouraged to live in 
mainstream  society
[31],  with  their  wellbeing  largely  dependent  on  caregivers  at  home  or  in 
community placements.  An inadvertent adverse effect of normalisation has been a reduction in the 
number of appropriately trained and experienced health professionals 
[32,33], resulting in increased 
workloads for general practitioners and greater burdens on families and carers.  The development of 
additional illnesses in the fourth to sixth decades ensures that a lengthy period of specialist care will 
be  required  during  the  remaining  years  of  life,  now  potentially  spanning  more  than  30  years.  
However,  the  management  of  health  care  for  people  after  18  years  of  age  is  ill-defined,  with 
continuity of care often fragmented, reluctance from both families and paediatric practitioners to 
initiate the transition to adult-based services
[34], and in some cases a preference to remain linked to 
paediatric services
[35]. 
In a US cohort study of people with Down syndrome (median age of 28 years), half of the 
individuals  investigated  continued  to  utilize  child-focused  providers  in  some  capacity
[20].    This 
blurring of the transition to adulthood creates the incongruity that adults with Down syndrome are 
encouraged to be independent members of society, yet their health care regimens remain largely 
unmapped.  Controversy also Questions remains with respect to the surrounding which medical 
specialities that can most appropriately deliver their health care for people with Down syndrome in 
adulthood and old age, and whether community-based practitioners are sufficiently knowledgeable 
or experienced to administer the levels of advice and support needed. 
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Conclusion 
The  triple  challenges  identified  exist  because  of  the  significant  increase  in  the  life 
expectancy of people with Down syndrome in recent decades, equating to almost one additional 
year of survival for every year passed
[5].  Detailed rResearch into related changes in their age-
related health profiles is therefore essential, both for people with the disorder and their families, is 
essentialif  progress  towards  health  and  social  equality  for  people  with  Down  syndrome  is  to 
continue. 
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Figure 1 legend: 
  Probability of developing five common disease states per decade of life for people with Down 
syndrome compared to the general population: a) Visual impairment 
[16,22]; b) Hearing impairment 
[15,22]; c) Epilepsy 
[18,22]; d) Thyroid disorders 
[19,22]; e) Dementia 
[17,21]. 
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